Med Ed Report briefs: August 2013

Share this article:
Marissa Seligman
Marissa Seligman

Marissa Seligman, chief compliance officer and SVP for regulatory and clinical affairs at Pri-Med since 2002, is set to join Clinical Care Options as COO/GM this month. Lynn Long, Pri-Med president/COO cited Seligman's “steady voice for the value of CME” during a “period of great change” for the profession.

Global Academy for Medical Education, in a joint sponsorship with University of Louisville School of Medicine, launched its Click for Credit activity where primary care clinicians can get CMEs for reading peer-reviewed articles and answering questions. In May, Doximity launched a similar service in collaboration with Cleveland Clinic.

The Association of American Medical Colleges and the American Psychological Association announced a collaboration to expand a free, online collection of mental health educational resources for HCPs and med students.

KnowledgePoint360 split one of its largest agencies, ACUMED, in two, creating Seren Communications, which will provide communication and education services like content development, publication support, meetings and congresses. Melissa Piper will serve as president.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?